Congratulations goes out to Dr. Warner Wang and Abbey Cox, PA-C and their team at WVU Medicine Camden Clark Medical Center for completing their first Enterra® Therapy implant! Thank you for helping increasing access to this advanced therapy option and offering hope and help to your #gastroparesis patients. #GPawareness #gastroenterology #nausea #vomiting Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: lnkd.in/eCr5zfhK MKT-SM-02522, Rev A
Enterra Medical, Inc.
Medical Equipment Manufacturing
Minneapolis, Minnesota 3,879 followers
Helping more people find relief from nausea and vomiting symptoms of gastroparesis through Enterra® Therapy.
About us
Enterra Medical is a medical device company dedicated to a singular focus: helping more people with chronic gastroparesis live better lives by advancing technology, expanding clinical science, and accelerating access to the Enterra® Therapy.* In order to increase investment and focus on the therapy, Enterra Medical was formed in 2022 and has begun the process to assume ongoing responsibility of Enterra Therapy from Medtronic. This process began with commercial responsibilities and will continue to expand to other aspects of the business. Medtronic remains a strong operational partner in this new management model and will continue to handle customer and patient support until Enterra Medical is fully equipped to assume those functions. Gastroparesis is a condition in which food moves through the stomach too slowly, causing chronic nausea and vomiting. Enterra Therapy, approved by the FDA under a Humanitarian Device Exemption in 2000, may be a surgical option for certain people who are unable to control chronic symptoms of gastroparesis.* It is the first and only implantable therapy for Gastric Electrical Stimulation, and over 15,000 people have received Enterra Therapy to help resume everyday activities. Consult with a doctor to see if Enterra Therapy may be an option for you. *Humanitarian Device. Enterra Therapy is authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Visit www.enterramedical.com/important-safety-information/ for important safety information.
- Website
-
http://www.enterramedical.com
External link for Enterra Medical, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Minneapolis, Minnesota
- Type
- Privately Held
- Founded
- 2022
- Specialties
- nausea, vomiting, gastroparesis, diabetes, gastric electrical stimulation, neurostimulation, neurostimulator, GES, and intractable nausea
Locations
-
Primary
Get directions
Minneapolis, Minnesota, US
Employees at Enterra Medical, Inc.
Updates
-
Congratulations to Dr. Eric Acheson for completing your first #EnterraTherapy case at St. David's Georgetown Hospital in Georgetown, TX. Thank you, Dr. Acheson, for offering hope and help to your #gastroparesis patients and increasing patient access to this advanced therapy option. #nausea #vomiting #gastroenterology #GPawareness Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. Rx Only. Review Important Safety Information: lnkd.in/eCr5zfhK MKT-SM-02380, Rev A
-
-
We invite all attendees of the American Foregut Society (AFS) Annual Meeting to join us for a special Lunch & Learn session sponsored by Enterra Medical on Friday, September 27th, from 12:00 PM to 1:30 PM. The session, titled "Evolutions in Gastroparesis and Gastric Electrical Stimulation: The Past, Present, and Future," will feature speakers Drs. Reena Chokshi and Joseph Sujka, who will share their knowledge and expertise on this important topic. Lunch will be served. We hope to see you there for what will sure to be an engaging discussion! Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02372, Rev A
-
-
Don’t miss out on an exciting scientific session at the American Foregut Society's (AFS) Annual Meeting, featuring Keynote Speaker Dr. Michael Awad from the Washington University School of Medicine. Dr. Awad will present on the topic "When Gastric Neurostimulation?" during the session on #gastroparesis. This session is scheduled for Friday, September 27 at 11:30 a.m., at the Gaylord Rockies Resort & Convention Center. Attendees will gain valuable insights into the latest advancements in gastric neurostimulation for the treatment of gastroparesis. If you're interested in cutting-edge approaches to foregut health, this session is a must-attend! #gastricneurostimulation #AFS2024 Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02372, Rev A
-
-
For those attending the American Foregut Society's (AFS) 2024 Annual Meeting, we invite you to visit Enterra Medical at booth #24. Discover the latest insights on #gastroparesis and learn about Enterra® Therapy—the first and only device specifically designed to target the #nausea and #vomiting symptoms associated with diabetic or idiopathic gastroparesis. Explore how this advanced treatment option is offering hope and help for your gastroparesis patients. #AFS2024 #gastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02372, Rev A
-
-
As #GastroparesisAwarenessMonth has come to a close, we’re grateful for the Enterra Medical team’s passion and dedication in raising awareness and support for those living with #gastroparesis. This year, our team participated in the Dash ‘N Smash event, walking, running, and rallying together to raise funds and education for this important cause. 💚👟 Our commitment doesn’t end here. We continue to work every day towards helping gastroparesis patients reclaim their lives and take their seat back at the table. Check out this compilation video of our team in action and join us in celebrating the progress and support we’re building together! #GPPieFaceChallenge #GastroparesisAwareness #GPAwarenessMonth #SmashGP #TakeYourSeatBack #gastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/eCr5zfhK MKT-SM-02460, Rev A
-
Enterra Medical, Inc. reposted this
Join us at our FREE online event to learn all about gastroparesis. Gastroparesis is a condition that means stomach (gastro) paralysis (paresis). Whether you’re living with it, supporting someone who has it, or you're curious to learn more, this event is for you. You’ll hear from experts like gastroenterologist Dr Ray Shidrawi and specialist dietitian Bethany Hallam, as well as people living with gastroparesis. Plus, you'll have the chance to ask the experts your questions! When? Thursday 26 September, 5:30 - 6:30pm GMT 1 Where? Online (join from anywhere!) How? Sign up via the link here: https://lnkd.in/eAukHPqv Don't miss out on this opportunity to learn, connect, and find support. Together, we can get to grips with guts 💚 #Gastroparesis #GutHealth #DigestiveHealth #ChronicIllness #InvisibleIllness #GastroparesisAwareness #Awareness #RareDisease #HealthEducation #Webinar #GutsUK #GutsCharityUK
-
-
Enterra Medical is pleased to announce that we will be attending this year’s Gastroenterology & Hepatology Advanced Practice Providers (NPs & PAs) GHAPP conference – September 12-14. Make sure to visit us at table #28 to learn about Enterra® Therapy, the first and only device of its kind targeting the #nausea and #vomiting symptoms associated with #gastroparesis from diabetic or idiopathic origins. #GHAPP #gastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02337, Rev A
-
-
Katie Harris is no stranger to a challenge. As an experienced social worker, she's accustomed to advocating for others. As an Enterra® Therapy recipient, she knows what it's like to live with #gastroparesis. Listen as she shares her powerful story, in her own words: https://lnkd.in/gKwFEeFy #GPAwareness #nausea #vomiting #gastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02112, Rev A
-
-
One thing we don’t always talk about when it comes to #gastroparesis? The toll it takes on patients’ partners and caregivers who walk alongside their loved ones on the long road to relief. Now, after having supported her husband for 15 years, Dee Dee reflects on her journey as a wife and caregiver. Read her story here: https://lnkd.in/gQvqvpWD #GPAwareness #nausea #vomiting #gastroenterology Humanitarian Device. Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. RX only. Review important safety information: https://lnkd.in/gYjd8mKi MKT-SM-02112, Rev A
-